Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$774M |
| 2 |
Intuitive Surgical
ISRG
|
+$654M |
| 3 |
S&P Global
SPGI
|
+$464M |
| 4 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$326M |
| 5 |
CELG
Celgene Corp
CELG
|
+$243M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
FedEx
FDX
|
+$591M |
| 2 |
Broadcom
AVGO
|
+$550M |
| 3 |
Monster Beverage
MNST
|
+$408M |
| 4 |
Booking.com
BKNG
|
+$377M |
| 5 |
McDonald's
MCD
|
+$371M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.27% |
| 2 | Consumer Discretionary | 16.23% |
| 3 | Healthcare | 15.49% |
| 4 | Financials | 12.97% |
| 5 | Communication Services | 11.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
Aptiv
APTV
$12.3B
| $50.5M | 0.05% |
602,262
-395,122
| -40% | -$36.1M |
|
252
BWX Technologies
BWXT
$15.2B
| $50M | 0.05% |
799,145
-92,870
| -10% | -$5.88M |
|
253
Aramark
ARMK
$15.1B
| $49.7M | 0.05% |
1,600,838
+264,838
| +20% | +$7.73M |
|
254
Neurocrine Biosciences
NBIX
$18.7B
| $49.7M | 0.05% |
403,968
+3,556
| +0.9% | +$403K |
|
255
Cintas
CTAS
$82.7B
| $49.6M | 0.05% |
1,003,012
-440,988
| -31% | -$22.8M |
|
256
Texas Roadhouse
TXRH
$13.7B
| $48.8M | 0.05% |
704,816
+46,260
| +7% | +$3.14M |
|
257
McCormick & Company Non-Voting
MKC
$13.7B
| $48.6M | 0.04% |
737,436
-313,698
| -30% | -$19.4M |
|
258
Duke Energy
DUK
$98.4B
| $47.9M | 0.04% |
599,030
| – | – |
|
259
Celanese
CE
$4.91B
| $47.9M | 0.04% |
419,954
-107,128
| -20% | -$12.3M |
|
260
Madrigal Pharmaceuticals
MDGL
$11.4B
| $47.8M | 0.04% |
223,371
+61,586
| +38% | +$15.5M |
|
261
IQVIA
IQV
$39.1B
| $47.2M | 0.04% |
363,952
-61,755
| -15% | -$7.42M |
|
|
MRTX
262
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $47M | 0.04% |
998,504
+383,785
| +62% | +$21.4M |
|
263
American Water Works
AWK
$26.7B
| $46M | 0.04% |
523,236
-390,748
| -43% | -$34.4M |
|
|
ADSW
264
DELISTED
Advanced Disposal Services Inc
ADSW
| $45.4M | 0.04% |
1,678,268
-217,055
| -11% | -$5.57M |
|
|
IMMU
265
DELISTED
Immunomedics Inc
IMMU
| $45M | 0.04% |
2,161,515
+15,952
| +0.7% | +$378K |
|
266
Take-Two Interactive
TTWO
$46.3B
| $44.9M | 0.04% |
325,117
+64,539
| +25% | +$8.23M |
|
267
NiSource
NI
$21.6B
| $44.8M | 0.04% |
1,798,299
-1,450,476
| -45% | -$38.4M |
|
268
Adecoagro
AGRO
$1.47B
| $44.4M | 0.04% |
6,046,638
-135,220
| -2% | -$1.09M |
|
269
eBay
EBAY
$50.4B
| $43.8M | 0.04% |
1,326,962
-466,903
| -26% | -$16.2M |
|
270
Hyatt Hotels
H
$16.6B
| $43.4M | 0.04% |
545,706
-247,136
| -31% | -$19.4M |
|
|
ACC
271
DELISTED
American Campus Communities, Inc.
ACC
| $43.3M | 0.04% |
1,052,432
+543,804
| +107% | +$22.7M |
|
272
Align Technology
ALGN
$12.4B
| $42.6M | 0.04% |
108,801
+977
| +0.9% | +$360K |
|
273
Delta Air Lines
DAL
$58.3B
| $42.3M | 0.04% |
730,935
-65,835
| -8% | -$3.63M |
|
274
Bright Horizons
BFAM
$4.1B
| $41.9M | 0.04% |
355,148
-8,191
| -2% | -$925K |
|
|
GWR
275
DELISTED
Genesee & Wyoming Inc.
GWR
| $41.8M | 0.04% |
458,927
-48,199
| -10% | -$4.18M |
|
Similar funds
Jennison Associates's Q3 2018 Portfolio in Review
As of Q3 2018, Jennison Associates held 739 positions worth $109B, up 5.9% from $103B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Jennison Associates's Q3 2018 filing shows 86 new, 214 increased, 352 reduced and 81 closed positions. Its largest new stake was Tiffany & Co.: 1,169,094 shares worth $151M. The largest sale was FedEx, an estimated $591M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Jennison Associates's largest Q3 2018 buy was Tiffany & Co.: 1,169,094 shares worth $151M.
- Jennison Associates added most to AstraZeneca in Q3 2018, an estimated $774M increase.
- Jennison Associates's biggest Q3 2018 reduction was FedEx, cutting an estimated $591M.
- Jennison Associates fully exited Cheniere Energy Partners LP Holdings LLC in Q3 2018, selling an estimated $134M.
- Jennison Associates's ten largest holdings make up 30% of its $109B portfolio in Q3 2018.
- Jennison Associates opened 86 new positions and closed 81 in Q3 2018.
- Jennison Associates's portfolio value rose 5.9% quarter-over-quarter to $109B.
Based on Jennison Associates's 13F filing for Q3 2018, filed 8 Nov 2018.